Deflin Gayle - Insider Non-Derivative Transactions at Amphastar Pharmaceuticals, Inc. (AMPH) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jun 3, 2024, Deflin Gayle's relationship to Amphastar Pharmaceuticals, Inc. (AMPH) is Director, and currently has 5,792 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AMPH insiders.

Data Source: SEC.
Deflin Gayle - Insider Non-Derivative Transactions of AMPH Common Stock
Deflin Gayle - Insider Non-Derivative Transactions at AMPH
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jun 4, 2024 Acquisition -- (Common Stock) 3076 0 5792
Nov 15, 2023 Sell -- (Common Stock) 4163 55.45 2716
Jun 6, 2023 Acquisition -- (Common Stock) 2716 0 6879
May 19, 2023 Sell -- (Common Stock) 4519 44.01 4163
May 16, 2023 Sell -- (Common Stock) 1500 43.15 8682